Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Post by digger144on May 29, 2013 6:24pm
227 Views
Post# 21457613

Trend Change...

Trend Change...

Gone are the days of pushing the stock down at every opportunity...remember Canacord hitting it a penny at a time?....especially on low volume days.

We should easily push into the seventies once the Mill is up and running again.

The Mill has been idle since May 12, 2013...but...fear not...they have taken this opportunity to catch up on their list of "things to do" and regular maintenance...the Mill will soon come on stream, perhaps as early as tomorrow and will be pushed to the maximum to make up for lost time and quickly catch up to production targets. 

Remember...the regular routines will be "thrown out the window" in order for them to push production...the Mill can achieve impressive results when push comes to shove.

The Underground, namely the West Side Story is achieving impressive numbers and grade...the market will reward their efforts moving forward...the lastest quarter proved that...the market would like to see a repeat of those results moving forward into the next couple of quarters in order to value the company accordingly.  The reason for this is that one can skew the results by pushing through higher grades to make the numbers...but...that is not the case when it comes to Brigus...a lot of hard work and planning went into getting to where they are today.  The Mine Sequence is set up to achieve the targeted ounces and maintain them in to the future...Nice!

The  market will take notice and reward their efforts accordingly!

Digger144

P.S.  Overall Grade came in at 4.74 g/t last quarter...love it!

 

Bullboard Posts